MedDataX Logo

Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis

NCT ID: NCT02198950

Last Updated: 2020-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-11-30

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine wether the combined measurement of the soluble form of TREM-1, PCT and the determination of neutrophils CD64 expression could diagnose sepsis in critically ill patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Determination of the Nature of the Endogenous Ligand of TREM-1 and Its Use as a New Diagnostic Biomarker in Sepsis

NCT01903668

Sepsis
WITHDRAWN

Comparison the Value of Several Biomarkers of Sepsis

NCT01388725

Systemic Inflammatory Response Syndrome Sepsis
COMPLETED

Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients

NCT05911711

Sepsis
UNKNOWN

Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients

NCT06904001

Sepsis Sepsis and Septic Shock Infection
ENROLLING_BY_INVITATION

Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis

NCT01995448

Sepsis With Acute Organ Dysfunction
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critically Ill Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICU patients

all patients admitted into the ICU

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all consecutive patients admitted into the ICU

Exclusion Criteria

* absence of social protection
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gibot Sébastien

Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sebastien Gibot, MD, PhD

Role: STUDY_CHAIR

Central Hospital, Nancy, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bocage Hospital

Dijon, , France

Site Status

Central hospital

Nancy, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009-A00870-57

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Correlation Between PTP1B Expression and Organ Failure During Sepsis
NCT02295514 COMPLETED NA
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis
NCT06219135 RECRUITING
New Strategy to Predict Early Sepsis
NCT04118179 UNKNOWN
Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis
NCT04280497 RECRUITING NA
Evaluation of the Performance of a New Rapid Bacteremia Test in the Intensive Care Patient
NCT06241248 COMPLETED
Investigate the Activity of Endotoxin in Severe Sepsis
NCT01957254 TERMINATED
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 UNKNOWN
The Application of SERS and Metabolomics in Sepsis
NCT02213237 UNKNOWN
Diagnostic Performance of a New Bio-marker During Bacterial Sepsis
NCT02721134 COMPLETED NA
Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers
NCT02692053 UNKNOWN NA
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 UNKNOWN
The Impact of Coagulation Disorders on the Diagnosis and Prognosis of Sepsis
NCT05998733 UNKNOWN
The Early Coagulopathy for the Prognosis in Sepsis
NCT04582188 UNKNOWN
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
NCT06491966 RECRUITING
Sepsis: From Syndrome to Personalized Care
NCT04203979 RECRUITING
The Correlation Between The New Sepsis Scores - SOFA, Quick SOFA and Calibrated Automated Thrombogram Values
NCT02953002 COMPLETED
Sepse: Critical Analysis of New Sepse Definitions and Retrospective Evaluation of Sepse Protocol at a Tertiary Hospital in Brazil
NCT03217981 UNKNOWN
Hemodynamic Evaluation Using Microcirculation for Early Treatment of Septic Patients
NCT06910891 RECRUITING NA
TRIAGE: TRIage of Sepsis At emerGency dEpartment
NCT02739152 COMPLETED
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 RECRUITING PHASE4
Serial Measurement of Capillary Blood Lactate in the Management of Sepsis
NCT02180399 COMPLETED
Comparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis.
NCT02300415 UNKNOWN
Evaluation of bioMarkErs to Reduce Antibiotics Use in hospitalizeD nEonates
NCT03299751 COMPLETED NA
Droplet Digital PCR Combines With Transcriptome Analysis in Early Warning of Sepsis in the Emergency Department
NCT06028178 NOT_YET_RECRUITING
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 UNKNOWN NA